CCL: Therapeutic applications of computational chemistry and biology (TACBAC)

 Sent to CCL by: Jan Labanowski [janl^speakeasy.net]
 Subject: Fwd: Therapeutic applications of computational chemistry and biology
  (TACBAC)
 Wellcome Trust meeting on
 Therapeutic applications of computational chemistry and biology (TACBAC)
 WT Conference Centre, near Cambridge (UK)
 12-14 March 2012
 https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=263
  The conference will take place at the WT Conference Centre, near
 Cambridge (UK) on the 12-14 March 2012. This conference will bring
 together leading researchers investigating computational chemistry and
 biology techniques as applied to advancing our ability to predict,
 diagnose and modulate human disease. This broad and multidisciplinary
 meeting will explore the major challenges in drug discovery and
 development where innovation in computational approaches and tools can
 really make a significant and tangible contribution towards novel
 treatments.
 Each of the sessions, which progress from identifying disease mechanisms
 to implementing new therapeutic and diagnostic approaches in the clinic,
 will bring together experts in both the biomedical and the computational
 aspects of the topic under discussion.
  Session topics
 * Clinical implications of individual genomes
 * Metabolism and biomarkers
 * Computational systems biology
 * Discovery of chemical probes
 * Modelling xenobiotic metabolism
 Scientific Programme Committee:
 Lee Harland, Pfizer, UK
 John Overington, EMBL-European Bioinformatics Institute, Hinxton, UK
 Christoph Steinbeck, EMBL-European Bioinformatics Institute, Hinxton, UK
 Speakers include:
 Chas Bountra, Structural Genomics Consortium, UK
 Paul Flicek, EMBL-European Bioinformatics Institute, Hinxton, UK
 Ronald Frank, Helmholtz Centre for Infection Research, Germany
 Bobby Glen, University of Cambridge, UK
 Roy Goodacre, University of Manchester, UK
 Jules Griffin, University of Cambridge, UK
 Lee Harland, Pfizer, UK
 Aroon Hingorani, University College London, UK
 John Overington, EMBL-European Bioinformatics Institute, Hinxton, UK
 Julio Saez-Rodriguez, EMBL-European Bioinformatics Institute, Hinxton, UK
 Christoph Steinbeck, EMBL-European Bioinformatics Institute, Hinxton, UK
 Olivier Tabourieau, Center for Biological Sequence Analysis, Denmark
 For more details, please view the the conference website:
 https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=263